(Q39084782)

8 September 2017

title

Plasma levels of apolipoprotein E and risk of dementia in the general population (English)

1 reference

8 September 2017

1 reference

Børge G. Nordestgaard

series ordinal

3

object named as

Børge G Nordestgaard

0 references

Anne Tybjærg-Hansen

series ordinal

2

object named as

Anne Tybjaerg-Hansen

1 reference

8 September 2017

4

Ruth Frikke-Schmidt

1 reference

8 September 2017

1

Katrine L Rasmussen

1 reference

8 September 2017

publication date

13 January 2015

1 reference

8 September 2017

1 reference

8 September 2017

volume

77

1 reference

8 September 2017

issue

2

1 reference

8 September 2017

page(s)

301-311

1 reference

8 September 2017

1 reference

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

Apolipoprotein E in Alzheimer's disease and other neurological disorders

21 January 2018

1 reference

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

21 January 2018

1 reference

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

21 January 2018

1 reference

Genome-wide analysis of genetic loci associated with Alzheimer disease

21 January 2018

1 reference

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

21 January 2018

1 reference

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

21 January 2018

1 reference

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

21 January 2018

1 reference

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models

21 January 2018

1 reference

Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man

21 January 2018

1 reference

Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease

21 January 2018

1 reference

Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease

21 January 2018

1 reference

Genetically elevated C-reactive protein and ischemic vascular disease

21 January 2018

1 reference

Genetically elevated lipoprotein(a) and increased risk of myocardial infarction

21 January 2018

1 reference

Gender- and age-specific contributions of additional DNA sequence variation in the 5' regulatory region of the APOE gene to prediction of measures of lipid metabolism

21 January 2018

1 reference

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

Underestimation of Risk Associations Due to Regression Dilution in Long-term Follow-up of Prospective Studies

21 January 2018

1 reference

High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia

21 January 2018

1 reference

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

21 January 2018

1 reference

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease

21 January 2018

1 reference

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease

21 January 2018

1 reference

Blood and plasma-based proteomic biomarker research in Alzheimer's disease

21 January 2018

1 reference

Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation

21 January 2018

1 reference

Differential metabolism of ApoE isoforms in plasma and CSF.

21 January 2018

1 reference

apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain

21 January 2018

1 reference

ADLAPH: A molecular haplotyping method based on allele-discriminating long-range PCR.

21 January 2018

1 reference

Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association

21 January 2018

1 reference

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

21 January 2018

1 reference

Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo.

21 January 2018

1 reference

Pericytes are required for blood-brain barrier integrity during embryogenesis

21 January 2018

1 reference

Pericytes regulate the blood-brain barrier

21 January 2018

1 reference

Total ApoE and ApoE4 isoform assays in an Alzheimer's disease case-control study by targeted mass spectrometry (n=669): a pilot assay for methionine-containing proteotypic peptides

21 January 2018

1 reference

In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.24326

1 reference

8 September 2017

1 reference